Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Factors Influencing Drug Absorption: Pharmaceutical Parameters01:28

Factors Influencing Drug Absorption: Pharmaceutical Parameters

834
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
834
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence01:27

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

226
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
226
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism01:21

Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism

883
Polymorphism refers to the existence of a drug substance in multiple crystalline forms, known as polymorphs. Recently, this term has been expanded to include solvates (forms containing a solvent), amorphous forms (non-crystalline forms), and desolvated solvates (forms from which the solvent has been removed).
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
883
Factors Influencing Drug Absorption: Drug Dissolution01:27

Factors Influencing Drug Absorption: Drug Dissolution

1.8K
The pharmacokinetic journey of drugs from solid oral dosage forms into systemic circulation is multifaceted. It begins with disintegration, a prerequisite ensuring a solid dosage form's subdivision into minute particles. Dissolution occurs next as these granulated entities solubilize in gastrointestinal fluids. This solubilization is crucial for the succeeding stage, permeation, which describes the traversal of the drug across the intestinal membrane and its subsequent entry into the blood...
1.8K
Bioavailability Enhancement: Drug Solubility Enhancement01:16

Bioavailability Enhancement: Drug Solubility Enhancement

499
Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...
499
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry01:20

Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry

733
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
733

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immunogenicity and protective efficacy of a live, oral cholera vaccine formulation stored outside-the-cold-chain for 140 days.

BMC immunology·2020
Same author

OLANZAPINE-PEG 6000 BINARY SYSTEMS: IN VITRO DISSOLUTION BEHAVIOR, PHYSICOCHEMICAL CHARACTERIZATION AND MATHEMATICAL MODELING.

Acta poloniae pharmaceutica·2015
See all related articles

Related Experiment Video

Updated: May 4, 2026

A Package of Established Analytical Tools to Investigate the Solid-State Alteration of Lipid-Based Excipients
11:27

A Package of Established Analytical Tools to Investigate the Solid-State Alteration of Lipid-Based Excipients

Published on: August 9, 2022

1.8K

Characterization of olanzapine-solid dispersions.

Venkateskumar Krishnamoorthy, Arunkumar Nagalingam, Verma Priya Ranjan Prasad

    Iranian Journal of Pharmaceutical Research : IJPR
    |December 24, 2013
    PubMed
    Summary

    Solid dispersion technique significantly enhances olanzapine

    Keywords:
    Differential scanning calorimetryFourier transform infrared spectroscopy.Near infra red spectroscopyPregelatinised starch Sodium starch glycollateX ray diffraction

    More Related Videos

    Dispersion of Nanomaterials in Aqueous Media: Towards Protocol Optimization
    09:35

    Dispersion of Nanomaterials in Aqueous Media: Towards Protocol Optimization

    Published on: December 25, 2017

    30.9K
    Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs
    08:18

    Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs

    Published on: July 27, 2022

    1.4K

    Related Experiment Videos

    Last Updated: May 4, 2026

    A Package of Established Analytical Tools to Investigate the Solid-State Alteration of Lipid-Based Excipients
    11:27

    A Package of Established Analytical Tools to Investigate the Solid-State Alteration of Lipid-Based Excipients

    Published on: August 9, 2022

    1.8K
    Dispersion of Nanomaterials in Aqueous Media: Towards Protocol Optimization
    09:35

    Dispersion of Nanomaterials in Aqueous Media: Towards Protocol Optimization

    Published on: December 25, 2017

    30.9K
    Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs
    08:18

    Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs

    Published on: July 27, 2022

    1.4K

    Area of Science:

    • Pharmaceutical Technology
    • Drug Delivery Systems

    Background:

    • Olanzapine exhibits poor aqueous solubility, limiting its therapeutic efficacy.
    • The solid dispersion technique offers a promising approach to improve the solubility of poorly soluble drugs.

    Purpose of the Study:

    • To enhance the aqueous solubility and dissolution rate of olanzapine.
    • To evaluate the effectiveness of pregelatinised starch (PGS) and sodium starch glycollate (SSG) as carriers for olanzapine solid dispersions.

    Main Methods:

    • Solid dispersions of olanzapine were prepared using PGS and SSG at various drug-carrier ratios (1:1 to 1:10) via the dispersion method.
    • Characterization involved phase solubility, in-vitro release, saturation solubility, permeation, wettability, X-ray diffraction (XRD), and Fourier-transform infrared (FTIR) spectroscopy.

    Main Results:

    • Solid dispersions demonstrated significantly higher solubility and improved in-vitro drug release compared to pure olanzapine.
    • The optimal drug-polymer ratio of 1:10 (olanzapine:carrier) yielded the best release profile.
    • XRD and FTIR analyses confirmed reduced crystallinity and carrier inertness, respectively.

    Conclusions:

    • Pregelatinised starch (PGS) and sodium starch glycollate (SSG) are effective carriers for improving the aqueous solubility of olanzapine.
    • The solid dispersion technique is a viable strategy for enhancing the dissolution and bioavailability of poorly soluble drugs like olanzapine.